Skip to main content
    M

    MacroGenics Inc (MGNX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $2.17
    -0.03 (-1.36%)

    Market Cap: $140.60M

    Last updated: Nov 17, 2026 at 11:06 AM ET

    MacroGenics Inc (MGNX) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to MacroGenics are Genelux Corporation Common Stock (GNLX), enGene Therapeutics (ENGN) and Invivyd (IVVD). By market cap, MacroGenics ranks 7th of the 13 companies on this page; Greenwich Lifesciences (GLSI) is the largest at $219.29M.

    Peer Comparison

    MGNX's revenue growth of -64.8% is below the peer median of 0.0%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    MacroGenics (MGNX)$140.60MN/A1.2x-36.6%-108.7%-64.8%0.00%
    Genelux Corporation Common Stock (GNLX)$84.38MN/AN/A0.0%N/A-95.3%0.00%
    enGene Therapeutics Inc. (ENGN)$161.51MN/AN/A0.0%-42.2%0.0%0.00%
    Invivyd Inc. (IVVD)$171.58MN/A2.9x-183.9%N/A21.2%0.00%
    Immunic Inc (IMUX)$102.61MN/AN/A0.0%N/A0.0%0.00%
    Innate Pharma (IPHA)$154.15MN/A17.6x0.0%489.8%16.5%0.00%
    Molecular Partners AG ADR (MOLN)$112.71MN/AN/A0.0%N/A-100.0%0.00%
    Anixa Biosciences Inc (ANIX)$91.08MN/AN/A0.0%N/A0.0%0.00%
    Pmv Pharmaceuticals Inc (PMVP)$95.93MN/AN/A0.0%N/A0.0%0.00%
    NeOnc Technologies Holdings, Inc. Common Stock (NTHI)$141.66MN/AN/A0.0%N/A-100.0%0.00%
    Pyxis Oncology Inc (PYXS)$188.98MN/A11.6x0.0%N/A0.0%0.00%
    Greenwich Lifesciences Inc (GLSI)$219.29MN/AN/A0.0%N/A0.0%0.00%
    Compass Therapeutics Inc. (CMPX)$139.35MN/AN/A0.0%N/A0.0%0.00%
    Peer median$140.50MN/A11.6x0.0%223.8%0.0%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to MacroGenics, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    Genelux Corporation Common Stock (GNLX)
    Genelux Corporation, a clinical-stage biopharmaceutical company, focuses on developing next-generation oncolytic viral immunotherapies for patients suffering...
    GNLX competitors
    enGene Therapeutics Inc. (ENGN)
    enGene Holdings Inc., through its subsidiary enGene, Inc., is a clinical-stage biotechnology company that develops genetic medicines through the delivery...
    ENGN competitors
    Invivyd Inc. (IVVD)
    Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company, is focused on the discovery...
    IVVD competitors
    Immunic Inc (IMUX)
    Immunic, Inc., a clinical-stage biopharmaceutical company, develops a line of selective oral immunology therapies for the treatment of chronic autoimmune...
    IMUX competitors
    Innate Pharma (IPHA)
    Innate Pharma SA, a biotechnology company, discovers, develops and markets therapeutic antibodies for the treatment of oncological indications in France...
    Molecular Partners AG ADR (MOLN)
    Molecular Partners AG is a clinical-stage biopharmaceutical company. The company is headquartered in Schlieren, Switzerland.
    MOLN competitors
    Anixa Biosciences Inc (ANIX)
    Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases.
    ANIX competitors
    Pmv Pharmaceuticals Inc (PMVP)
    PMV Pharmaceuticals, Inc., a precision oncology company, is dedicated to the discovery and development of small molecule tumor agnostic therapies for p53...
    PMVP competitors
    NeOnc Technologies Holdings, Inc. Common Stock (NTHI)
    NeOnc Technologies Holdings, Inc. is a pioneering biotechnology firm dedicated to revolutionizing cancer treatment through its advanced immunotherapy...
    NTHI competitors
    Pyxis Oncology Inc (PYXS)
    Pyxis Oncology, Inc., a preclinical biotechnology company, is dedicated to developing antibody-drug conjugate (ADC) and monoclonal antibody (mAb)...
    PYXS competitors
    Greenwich Lifesciences Inc (GLSI)
    Greenwich LifeSciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development of new cancer immunotherapies for breast and other HER2 /...
    GLSI competitors
    Compass Therapeutics Inc. (CMPX)
    Compass Therapeutics, Inc. is a clinical-stage oncology-focused biopharmaceutical company developing proprietary antibody-based therapies to treat multiple...
    CMPX competitors

    Frequently Asked Questions About MGNX

    Who are MacroGenics' main competitors?

    The companies most similar to MacroGenics include Genelux Corporation Common Stock (GNLX), enGene Therapeutics (ENGN), Invivyd (IVVD), Immunic (IMUX) and Innate Pharma (IPHA), listed from the closest match.

    Who is MacroGenics' biggest competitor?

    Greenwich Lifesciences (GLSI) is the largest of the similar companies at $219.29M; Genelux Corporation Common Stock (GNLX) is the closest match by business profile, size, sector and industry.

    How does MGNX stock compare with its competitors?

    MGNX's P/S is 1.2x against a peer median of 11.6x; its net margin is -36.6% against a peer median of 0.0%.

    Which of MacroGenics' competitors pays a higher dividend?

    MacroGenics pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is MacroGenics bigger than its competitors?

    No. MacroGenics is 7th by market cap among the 13 companies on this page; the largest is Greenwich Lifesciences (GLSI) at $219.29M.